Treatment of non-Hodgkin lymphoma with point-of-care manufactured CAR T cells: a dual institution, phase 1 trial

This clinical trial was funded through University Hospitals Seidman Cancer Center and Washington University School of Medicine Institutional Funds. Correlative analyses were funded in part by the European Union-Next Generation EU-NRRP M6C2-Investment 2.1 Enhancement and strengthening of biomedical research in the NHS (project #PNRR-MAD-2022-12376059), and the Italian Ministry of Health Ricerca Finalizzata 2019 (project #RF-2019-12370243).

Authors

Institutions

Publication Details

Journal
EClinicalMedicine
Published
2025-03-01
DOI
https://doi.org/10.1016/j.eclinm.2025.103138
Citations
4
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
4.18
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Treatment of non-Hodgkin lymphoma with point-of-care manufactured CAR T cells: a dual institution, phase 1 trial

Boro Dropulić, David N. Wald, Kirsten M Boughan, Brenda Cooper et al.
4 citations
EClinicalMedicine
CAR-T cell therapy research
4.18
article

Treatment of non-Hodgkin lymphoma with point-of-care manufactured CAR T cells: a dual institution, phase 1 trial

Boro Dropulić, David N. Wald, Kirsten M Boughan, Brenda Cooper, Paolo F. Caimi, Jane Reese, Rimas J. Orentas, Zachary Jackson, Krishna Goparaju, Marcos de Lima, Ashish Sharma, Linda Eissenberg, Leland Metheny, Martina Di Trani, Rafick‐Pierre Sékaly, Carmelo Carlo‐Stella, Andrew Worden A.S, Julie Ritchey, Emily Craig Zabor, Folashade Otegbeye, John F. DiPersio, Kayla Zamborsky, Molly Gallogly, Winfried Krüger, Benjamin Tomlinson, Dina Schneider, Armin Ghobadi, Sarah Kleinsorge-Block, Jennifer Schiavone, Michael J. Kadan
article en
4 citations

Abstract

This clinical trial was funded through University Hospitals Seidman Cancer Center and Washington University School of Medicine Institutional Funds. Correlative analyses were funded in part by the European Union-Next Generation EU-NRRP M6C2-Investment 2.1 Enhancement and strengthening of biomedical research in the NHS (project #PNRR-MAD-2022-12376059), and the Italian Ministry of Health Ricerca Finalizzata 2019 (project #RF-2019-12370243).

EClinicalMedicineVol. 81
Seattle Children's Hospital (US), Cleveland Clinic (US), Humanitas University (IT), Emory University (US), Washington University in St. Louis (US), University Hospitals of Cleveland (US), The Ohio State University Wexner Medical Center (US), Fred Hutch Cancer Center (US), Louis Stokes Cleveland VA Medical Center (US), Lentigen Technology (United States) (US), Capital Caring (US), IRCCS Humanitas Research Hospital (IT), Case Comprehensive Cancer Center
Openalex Percentile: Top 6%
CAR-T cell therapy research
4.18
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.